NO983294D0 - Bowman-Birk inhibitor for hankjann dysfunksjon - Google Patents
Bowman-Birk inhibitor for hankjann dysfunksjonInfo
- Publication number
- NO983294D0 NO983294D0 NO983294A NO983294A NO983294D0 NO 983294 D0 NO983294 D0 NO 983294D0 NO 983294 A NO983294 A NO 983294A NO 983294 A NO983294 A NO 983294A NO 983294 D0 NO983294 D0 NO 983294D0
- Authority
- NO
- Norway
- Prior art keywords
- bowman
- birk inhibitor
- male dysfunction
- dysfunction
- male
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/56—Protease inhibitors from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Botany (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/588,462 US5961980A (en) | 1996-01-18 | 1996-01-18 | Bowman-birk inhibitor compositions and methods for the treatment of genitourinary diseases |
PCT/US1997/000643 WO1997025961A1 (en) | 1996-01-18 | 1997-01-16 | Bowman-birk inhibitor for male sexual dysfunction |
Publications (2)
Publication Number | Publication Date |
---|---|
NO983294D0 true NO983294D0 (no) | 1998-07-16 |
NO983294L NO983294L (no) | 1998-09-16 |
Family
ID=24353946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983294A NO983294L (no) | 1996-01-18 | 1998-07-16 | Bowman-Birk inhibitor for hankj°nn dysfunksjon |
Country Status (7)
Country | Link |
---|---|
US (1) | US5961980A (no) |
EP (1) | EP0925057A4 (no) |
JP (1) | JP2001513072A (no) |
KR (1) | KR19990077349A (no) |
AU (1) | AU711700B2 (no) |
NO (1) | NO983294L (no) |
WO (1) | WO1997025961A1 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
US6750229B2 (en) * | 1998-07-06 | 2004-06-15 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin pigmentation |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
US6767564B2 (en) | 2000-09-02 | 2004-07-27 | The Trustees Of The University Of Pennsylvania | Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
US6555143B2 (en) | 2001-02-28 | 2003-04-29 | Johnson & Johnson Consumer Products, Inc. | Legume products |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
JP4866728B2 (ja) * | 2003-08-01 | 2012-02-01 | ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルヴァニア | 筋萎縮及び筋縮退疾病の処置のためのボーマン−バークインヒビター組成物 |
US20080025966A1 (en) * | 2004-01-30 | 2008-01-31 | Currie Mark G | Methods And Compositions For The Treatment Of Gastrointestinal disorders |
WO2005091823A2 (en) * | 2004-03-01 | 2005-10-06 | The Regents Of The University Of California | The use of lunasin peptide as a transcriptional activator to prevent cancer and related methods for treatment, monitoring and prognosis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4793996A (en) * | 1984-11-14 | 1988-12-27 | Ann R. Kennedy | Method of making soybean extract inhibitor |
US5550042A (en) * | 1989-03-06 | 1996-08-27 | The Board Of Regents Of The University Of Texas System | Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same |
US5217717A (en) * | 1990-09-06 | 1993-06-08 | Central Soya Company, Inc. | Method of making soybean Bowman-Birk inhibitor concentrate and use of same as a human cancer preventative and therapy |
US5505946A (en) * | 1994-04-01 | 1996-04-09 | Trustees Of Univ Of Pa | Bowman-birk inhibitor concentrate compositions and methods for the treatment of pre-malignant tissue |
-
1996
- 1996-01-18 US US08/588,462 patent/US5961980A/en not_active Expired - Lifetime
-
1997
- 1997-01-16 EP EP97904775A patent/EP0925057A4/en not_active Withdrawn
- 1997-01-16 WO PCT/US1997/000643 patent/WO1997025961A1/en not_active Application Discontinuation
- 1997-01-16 AU AU17483/97A patent/AU711700B2/en not_active Ceased
- 1997-01-16 KR KR1019980705496A patent/KR19990077349A/ko not_active Application Discontinuation
- 1997-01-16 JP JP52615897A patent/JP2001513072A/ja active Pending
-
1998
- 1998-07-16 NO NO983294A patent/NO983294L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR19990077349A (ko) | 1999-10-25 |
NO983294L (no) | 1998-09-16 |
EP0925057A4 (en) | 2000-11-15 |
AU711700B2 (en) | 1999-10-21 |
JP2001513072A (ja) | 2001-08-28 |
US5961980A (en) | 1999-10-05 |
EP0925057A1 (en) | 1999-06-30 |
AU1748397A (en) | 1997-08-11 |
WO1997025961A1 (en) | 1997-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT936912E (pt) | Inibidores de cisteina protease | |
ID19198A (id) | Inhibitor metaloprotease heterosiklik | |
NO995433D0 (no) | Protease-inhibitorer | |
ID18416A (id) | Inhibitor metaloprotease diheterosiklik | |
NO20012980D0 (no) | Proteaseinhibitorer | |
ID18141A (id) | Inhibitor metaloprotease 1,3-diheterosiklik | |
NO981938D0 (no) | Proteaseinhibitorer | |
DK1004669T3 (da) | Hidtil ukendte differentieringsinhibitor | |
ATE334700T1 (de) | Refluxinhibitoren | |
NO992734D0 (no) | Serin-protease inhibitorer | |
DK0958287T3 (da) | Sulfamidmetalloprotease-inhibitorer | |
PL328307A1 (en) | Serinic protease inhibitors | |
NO995434D0 (no) | Proteaseinhibitorer | |
NO20003256D0 (no) | ACE inhibitor-MMP inhibitor kombinasjoner | |
NO995435D0 (no) | Protease-inhibitorer | |
ATE277074T1 (de) | Serine-protease-inhibitoren | |
NO995268D0 (no) | Proteaseinhibitorer | |
BR9707086A (pt) | Inibidores de proteinase aspartila | |
PL328875A1 (en) | Serinic protease inhibitors | |
DE69736109D1 (de) | Differenzierungsinhibitor | |
NO983294D0 (no) | Bowman-Birk inhibitor for hankjann dysfunksjon | |
NO975073D0 (no) | Lavtoksisk korrosjonshemmer | |
NO990116L (no) | Korrosjonsinhibering | |
NO992858D0 (no) | Inhibitor for portahypertensjon | |
DE69720957T2 (de) | Ace-hemmer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |